- Home
- CVBF vs OGN Comparison
CVBF vs OGN Comparison
Compare CVBF & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVBF
- OGN
- Stock Information
- Founded
- CVBF 1974
- OGN 1923
- Country
- CVBF United States
- OGN United States
- Employees
- CVBF N/A
- OGN N/A
- Industry
- CVBF Major Banks
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- CVBF Finance
- OGN Health Care
- Exchange
- CVBF Nasdaq
- OGN Nasdaq
- Market Cap
- CVBF 2.6B
- OGN 2.5B
- IPO Year
- CVBF N/A
- OGN N/A
- Fundamental
- Price
- CVBF $20.32
- OGN $10.39
- Analyst Decision
- CVBF Buy
- OGN Hold
- Analyst Count
- CVBF 4
- OGN 4
- Target Price
- CVBF $23.25
- OGN $18.00
- AVG Volume (30 Days)
- CVBF 579.4K
- OGN 3.8M
- Earning Date
- CVBF 10-22-2025
- OGN 10-30-2025
- Dividend Yield
- CVBF 3.91%
- OGN 0.77%
- EPS Growth
- CVBF N/A
- OGN N/A
- EPS
- CVBF 1.46
- OGN 2.69
- Revenue
- CVBF $507,999,000.00
- OGN $6,281,000,000.00
- Revenue This Year
- CVBF N/A
- OGN N/A
- Revenue Next Year
- CVBF $6.04
- OGN $1.36
- P/E Ratio
- CVBF $14.01
- OGN $3.86
- Revenue Growth
- CVBF N/A
- OGN N/A
- 52 Week Low
- CVBF $16.01
- OGN $8.01
- 52 Week High
- CVBF $24.58
- OGN $22.42
- Technical
- Relative Strength Index (RSI)
- CVBF 57.58
- OGN 66.34
- Support Level
- CVBF $19.70
- OGN $8.95
- Resistance Level
- CVBF $20.50
- OGN $9.64
- Average True Range (ATR)
- CVBF 0.41
- OGN 0.33
- MACD
- CVBF 0.07
- OGN 0.12
- Stochastic Oscillator
- CVBF 76.54
- OGN 97.96
About CVBF CVB Financial Corporation
CVB Financial Corp is the holding company for Citizens Business Bank. Citizens Business Bank offers banking, lending, and investing services. It provides a full complement of lending products, including commercial, agribusiness, consumer, SBA, real estate, and construction loans, as well as equipment and vehicle leasing. Commercial products include lines of credit and other working capital financing, accounts receivable lending and letters of credit.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.